• Je něco špatně v tomto záznamu ?

A Short Communication: Lamotrigine Levels in Milk, Mothers, and Breastfed Infants During the First Postnatal Month

I. Kacirova, M. Grundmann, H. Brozmanova,

. 2019 ; 41 (3) : 401-404. [pub] -

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc20006619

BACKGROUND: Lamotrigine has become the most frequently prescribed drug in the treatment of pregnant women with epilepsy. Although some relevant studies have found a wide milk/maternal serum as well as infant/maternal serum concentration ratio, different infant ages at the time of sampling and small number of patients preclude comparison. The aim of this study was to provide a consistent evaluation. METHODS: Data of 43 nursing women treated by lamotrigine were evaluated retrospectively. The authors followed the transport of lamotrigine during the first postnatal month from mothers to breastfed infants through maternal milk between the years 2002 and 2017. RESULTS: Lamotrigine concentrations varied from 1.1 to 14.9 mg/L in the maternal serum, from <0.66 to 9.1 mg/L in the milk and between <0.66 and 6.9 mg/L in the infant serum. The milk/maternal serum concentration ratio ranged from <0.18 to 0.74 and the infant/maternal serum concentration ratio measured between <0.15 and 0.74. Highly significant correlations were found between milk and maternal serum levels and between infant serum levels and milk, maternal serum levels, lamotrigine daily dose, and also maternal dose related to the body weight. CONCLUSIONS: The authors confirmed the wide range of the milk/maternal serum concentration ratio and the infant/maternal serum concentration ratio. Although the degree of lamotrigine exposure to the breastfed infants was smaller than during gestation, 16% of the infant serum levels measured were within the therapeutic range used for the general epileptic population. Lamotrigine concentration monitoring in breastfed infant, in our opinion, is the most relevant aspect for the analysis of actual lamotrigine exposure in infants, especially in those with clinical symptoms.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20006619
003      
CZ-PrNML
005      
20200525142502.0
007      
ta
008      
200511s2019 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1097/FTD.0000000000000604 $2 doi
035    __
$a (PubMed)30688868
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Kacirova, Ivana $u Department of Clinical Pharmacology, Faculty of Medicine, University of Ostrava. Department of Clinical Pharmacology and Laboratory Diagnostics, University Hospital Ostrava, Ostrava, Czech Republic.
245    12
$a A Short Communication: Lamotrigine Levels in Milk, Mothers, and Breastfed Infants During the First Postnatal Month / $c I. Kacirova, M. Grundmann, H. Brozmanova,
520    9_
$a BACKGROUND: Lamotrigine has become the most frequently prescribed drug in the treatment of pregnant women with epilepsy. Although some relevant studies have found a wide milk/maternal serum as well as infant/maternal serum concentration ratio, different infant ages at the time of sampling and small number of patients preclude comparison. The aim of this study was to provide a consistent evaluation. METHODS: Data of 43 nursing women treated by lamotrigine were evaluated retrospectively. The authors followed the transport of lamotrigine during the first postnatal month from mothers to breastfed infants through maternal milk between the years 2002 and 2017. RESULTS: Lamotrigine concentrations varied from 1.1 to 14.9 mg/L in the maternal serum, from <0.66 to 9.1 mg/L in the milk and between <0.66 and 6.9 mg/L in the infant serum. The milk/maternal serum concentration ratio ranged from <0.18 to 0.74 and the infant/maternal serum concentration ratio measured between <0.15 and 0.74. Highly significant correlations were found between milk and maternal serum levels and between infant serum levels and milk, maternal serum levels, lamotrigine daily dose, and also maternal dose related to the body weight. CONCLUSIONS: The authors confirmed the wide range of the milk/maternal serum concentration ratio and the infant/maternal serum concentration ratio. Although the degree of lamotrigine exposure to the breastfed infants was smaller than during gestation, 16% of the infant serum levels measured were within the therapeutic range used for the general epileptic population. Lamotrigine concentration monitoring in breastfed infant, in our opinion, is the most relevant aspect for the analysis of actual lamotrigine exposure in infants, especially in those with clinical symptoms.
650    _2
$a antikonvulziva $x krev $x metabolismus $x terapeutické užití $7 D000927
650    _2
$a kojení $x metody $7 D001942
650    _2
$a epilepsie $x krev $x farmakoterapie $x metabolismus $7 D004827
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a novorozenec $7 D007231
650    _2
$a lamotrigin $x krev $x metabolismus $x terapeutické užití $7 D000077213
650    _2
$a mateřské mléko $x metabolismus $7 D008895
650    _2
$a matky $7 D009035
650    _2
$a těhotenství $7 D011247
650    _2
$a retrospektivní studie $7 D012189
650    _2
$a sérum $x chemie $7 D044967
655    _2
$a časopisecké články $7 D016428
700    1_
$a Grundmann, Milan $u Department of Clinical Pharmacology, Faculty of Medicine, University of Ostrava.
700    1_
$a Brozmanova, Hana $u Department of Clinical Pharmacology, Faculty of Medicine, University of Ostrava. Department of Clinical Pharmacology and Laboratory Diagnostics, University Hospital Ostrava, Ostrava, Czech Republic.
773    0_
$w MED00004503 $t Therapeutic drug monitoring $x 1536-3694 $g Roč. 41, č. 3 (2019), s. 401-404
856    41
$u https://pubmed.ncbi.nlm.nih.gov/30688868 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20200511 $b ABA008
991    __
$a 20200525142501 $b ABA008
999    __
$a ok $b bmc $g 1525477 $s 1096675
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 41 $c 3 $d 401-404 $e - $i 1536-3694 $m Therapeutic drug monitoring $n Ther Drug Monit $x MED00004503
LZP    __
$a Pubmed-20200511

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace

Nahrávání dat ...